0 results for 'Merck'
Antitrust Class Action Filed Against Merck for its Rotavirus Vaccine, RotaTeq
This suit was surfaced by Law.com Radar. Read the complaint here.Offer or Quote—Contract Question Remains the Source of Patent Peril
In Pfaff v. Wells Electronics, 525 U.S. 55 (1998), the U.S. Supreme Court articulated a two-prong test, holding the on-sale bar applies when, before the critical date (one year prior to the filing date of a patent application), the claimed invention was the subject of a commercial offer for sale and ready for patenting.'Unexplained Large Reverse Payment': Zetia Antitrust Claims Scheduled for Jury Trial in April
Plaintiffs claimed the two companies "conspired to delay the introduction of generic ezetimibe to the market, in violation of Sections 1 and 2 of the Sherman Act."Dan Weiner of Hughes Hubbard & Reed on the Benefits of 'Deep Industry Focus'
"As the saying goes, 'A little knowledge is a dangerous thing'; we pride ourselves in knowing both the law and the subject matter of our cases, inside and out."Playing the 'Long Game,' Goodwin's Profits Drop 6% Even as Revenue Rises Double Digits
Speaking shortly after the firm's layoffs, chair Robert Insolia said Goodwin's size is now appropriate for the amount of work it has, and the firm remains committed to long-term growth over short-term results.View more book results for the query "Merck"
Litigation Leaders: Dan Weiner of Hughes Hubbard & Reed on the Benefits of 'Deep Industry Focus'
"As the saying goes, 'A little knowledge is a dangerous thing'; we pride ourselves in knowing both the law and the subject matter of our cases, inside and out."Man Sues Law Firm and Others, Seeking $5M for Lost Job Chance
This suit was surfaced by Law.com Radar. Read the complaint here.A Review of Cyber Coverage Decisions From 2022: A Policyholder's Perspective
The article summarizes the key cyber coverage decisions of 2022—and from a policyholder's viewpoint, the good, the bad, and the in-between.Supreme Court To Revisit the Patent Enablement Standard
The decision in 'Amgen v. Sanofi' has the potential to have a significant impact on inventors and patent drafters, and the breadth with which they may be able to claim their inventions.Trending Stories
Unlocking the Power of Early Case Assessment Workflows
Brought to you by Integreon
Download Now
Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House
Brought to you by LexisNexis®
Download Now
Insights and Strategies for Effective Succession Planning in AM Law 100 Firms
Brought to you by Gallagher
Download Now
State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now